ZEPP HEALTH CORP Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
ZEPP HEALTH CORP (ZEPP) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $623.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-24.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2026-04-24
CNY
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|
| 2023-12-31 | 58.35M CNY 20-F · filed 2024-04-23 |
| 2022-12-31 | -540.70M CNY 20-F · filed 2024-04-23 |
| 2021-12-31 | -750.65M CNY 20-F · filed 2024-04-23 |
| 2020-12-31 | 515.09M CNY 20-F · filed 2023-04-24 |
| 2019-12-31 | 340.90M CNY 20-F · filed 2022-04-28 |
| 2018-12-31 | 1.02B CNY 20-F · filed 2021-04-19 |
| 2017-12-31 | 219.54M CNY 20-F · filed 2020-04-23 |
| 2016-12-31 | -72.10M CNY 20-F · filed 2019-04-12 |
| 2015-12-31 | 202.38M CNY 20-F · filed 2018-04-27 |
USD
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month as first filed |
|---|---|---|
| 2025-12-31 | $623.00K 20-F · filed 2026-04-24 | |
| 2024-12-31 | -$25.49M 20-F · filed 2026-04-24 | |
| 2023-12-31 | $8.65M 20-F · filed 2026-04-24 | $8.22M 20-F · filed 2024-04-23 |
| 2022-12-31 | -$80.98M 20-F · filed 2025-04-25 | -$78.40M 20-F · filed 2023-04-24 |
| 2021-12-31 | -$117.79M 20-F · filed 2022-04-28 | |
| 2020-12-31 | $78.94M 20-F · filed 2021-04-19 | |
| 2019-12-31 | $48.97M 20-F · filed 2020-04-23 | |
| 2018-12-31 | $148.63M 20-F · filed 2019-04-12 | |
| 2017-12-31 | $33.74M 20-F · filed 2018-04-27 |